EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence

Tina I Bui iD, Christopher W Farnsworth iD, Neil W Anderson iD

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.00620-24 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Tina I Bui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV Antibodies, Sensitivity and Specificity, Point-of-Care Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many emergency departments (ED) use rapid human immunodeficiency virus (HIV) antibody tests as screening tools, despite limited sensitivity for detecting acute HIV infections. In a 4-year retrospective analysis of 1,192 patients, we evaluated the performance of a third-generation rapid HIV antibody assay tested at point-of-care (POC, Chembio Sure Check HIV 1/2) against in-lab fourth-generation screening (Abbott Architect Ag/Ab Combo). Compared to complete algorithmic testing, the POC test demonstrated a 92.5% sensitivity (95% CI = 84.6–96.5), 98.1% specificity (95% CI = 97.1–98.8), 99.5% negative predictive value (NPV; 95% CI = 98.8–99.8), and a 77.9% positive predictive value (PPV; 95% CI = 68.6–85.1). Notably, the POC test failed to detect 100% (3/3) of acute HIV infections (defined as Fiebig stage 2) and 3.8% (2/52) established HIV infections, where viral loads were 5.9, 6.7, and >7 log 10 copies/mL. Symptoms such as fever, nausea/vomiting, malaise, headache, and photophobia were significantly associated with acute HIV infections diagnosed in the ED. The rapid HIV antibody test demonstrated high sensitivity, specificity, and NPV in our study population, reaffirming its effectiveness as a valuable screening tool. However, the low PPV and 100% failure to detect acute HIV infections underscore the importance of prioritizing in-lab fourth-generation HIV antigen/antibody combination immunoassays in cases of suspected acute HIV infection to ensure a timely and accurate diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV AntibodiesSensitivity and SpecificityPoint-of-Care SystemsHumansRetrospective StudiesMaleFemaleAdultMiddle AgedYoung AdultPredictive Value of TestsAgedAdolescentPrevalencePoint-of-Care TestingEmergency Service, HospitalHIV Testing

Stichwörter der Autor:innen

HIVacute HIVpoint-of-carerapid testing

Substanzen

HIV Antibodies

Autor:innen und Institutionen

  • Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA.
  • Department of Pathology, University Hospitals Health System, Cleveland, Ohio, USA.

ORCID-Profile: Tina I Bui, Christopher W Farnsworth, Neil W Anderson

Zitieren

APA

Bui, T. I., Farnsworth, C. W., & Anderson, N. W. (2024). Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00620-24

Vancouver

Bui TI, Farnsworth CW, Anderson NW. Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00620-24

BibTeX
@article{Bui2024,
  author = {Bui, Tina I and Farnsworth, Christopher W and Anderson, Neil W},
  title = {Evaluation of a point-of-care rapid HIV antibody test with insights into acute HIV symptomatology in a population with low prevalence},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.00620-24}
}
Kostenlos starten →